Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$111,056,494
+$3,735,900 QoQ
Shares Held
905,992
-11.0% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. PTGX ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,056,494 | 905,992 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $107,320,594 | 1,018,222 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $76,773,952 | 879,024 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $51,042,084 | 768,359 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $48,027,581 | 868,963 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $24,039,993 | 497,105 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $20,856,156 | 540,315 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $28,288,035 | 628,623 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $11,964,399 | 345,293 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $54,384,865 | 1,879,878 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $27,328,819 | 1,191,837 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $7,155,782 | 429,004 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $15,964,935 | 578,021 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,121,730 | 1,570,510 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $26,604,215 | 2,438,517 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $18,778,454 | 2,227,575 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,051,731 | 1,776,452 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $31,662,595 | 1,337,103 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,673,625 | 107,416 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,404,860 | 474,315 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,133,968 | 69,830 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $122,324 | 4,723 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $675,137 | 33,489 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $155,323 | 7,945 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $190,337 | 10,778 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,622 | 1,363 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||